Autopsy report · NCT01126866

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

“recruiting inadequate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months after it had already started.
• Ran for about 2 years before it stopped.
• 35 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Center for Tumor Diseases, Heidelberg

Sponsor type

University, hospital or other

Conditions

Colorectal Carcinoma

Interventions

intensified chemotherapy (FOLFOXIRI/Bevacizumab)

Participants

35 (planned, not actual)

Sites

1

Countries

Germany

Trials that died the same way

• Expanding Access to Comprehensive Geriatrics Care Via Telehealth
  “Inadequate recruitment” (90% match in meaning)
• Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
  “Poor recruiting” (88% match in meaning)
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (86% match in meaning)
• Use of Patient-Controlled Analgesia in Acute Pancreatitis
  “inadequate recruitment despite efforts” (86% match in meaning)
• The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men
  “lack of recruiting progress” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.